TIM-3-话题@MedSci

#TIM-3#

7篇内容 | 371人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2183691, encodeId=8c3a218369128, content=<a href='/topic/show?id=daf52906537' target=_blank style='color:#2F92EE;'>#免疫治疗#</a> <a href='/topic/show?id=aad38494640' target=_blank style='color:#2F92EE;'>#脑瘤#</a> <a href='/topic/show?id=026059e658' target=_blank style='color:#2F92EE;'>#DIPG#</a> <a href='/topic/show?id=3dc91e454d3' target=_blank style='color:#2F92EE;'>#TIM-3#</a> <a href='/topic/show?id=66eb1104e9da' target=_blank style='color:#2F92EE;'>#弥漫型内因性脑桥胶质瘤#</a>, objectTitle=Cancer Cell：临床前研究显示阻断TIM-3是潜在的DIPG脑瘤免疫治疗方法, objectType=article, longId=809122, objectId=b8d5809122fc, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medical-team-discussing-together-in-the-hallway-PJWSSDB.jpg, objectUrl=/article/show_article.do?id=b8d5809122fc, replyNumber=0, likeNumber=26, createdTime=2024-01-24, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=b8d5809122fc, moduleTitle=Cancer Cell：临床前研究显示阻断TIM-3是潜在的DIPG脑瘤免疫治疗方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b8d5809122fc)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1795724, encodeId=08ab1e957247d, content=<a href='/topic/show?id=3dc91e454d3' target=_blank style='color:#2F92EE;'>#TIM-3#</a>, objectTitle=Clin Cancer Res：PD-L1抗体单药或联合TIM-3抗体在MSI-H/dMMR晚期肿瘤中的抗肿瘤活性和安全性, objectType=article, longId=220797, objectId=5c23220e97c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c23220e97c1, replyNumber=0, likeNumber=27, createdTime=2022-07-06, rootId=0, userName=cmsvly, userId=aad0444, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c23220e97c1, moduleTitle=Clin Cancer Res：PD-L1抗体单药或联合TIM-3抗体在MSI-H/dMMR晚期肿瘤中的抗肿瘤活性和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5c23220e97c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795723, encodeId=962f1e957230e, content=<a href='/topic/show?id=3dc91e454d3' target=_blank style='color:#2F92EE;'>#TIM-3#</a>, objectTitle=Clin Cancer Res：α-PD-L1抗体±α-TIM-3抗体治疗MSI-H/dMMR肿瘤的活性和安全性, objectType=article, longId=216685, objectId=110121668513, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=110121668513, replyNumber=0, likeNumber=26, createdTime=2022-07-05, rootId=0, userName=cmsvly, userId=aad0444, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=110121668513, moduleTitle=Clin Cancer Res：α-PD-L1抗体±α-TIM-3抗体治疗MSI-H/dMMR肿瘤的活性和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=110121668513)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795722, encodeId=79e91e9572247, content=<a href='/topic/show?id=3dc91e454d3' target=_blank style='color:#2F92EE;'>#TIM-3#</a>, objectTitle=Sci Rep：高CD3和ICOS及低TIM-3表达预测食管鳞状细胞癌切除后的生存率良好, objectType=article, longId=186031, objectId=fef1186031b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fef1186031b8, replyNumber=0, likeNumber=35, createdTime=2020-10-02, rootId=0, userName=cmsvly, userId=aad0444, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fef1186031b8, moduleTitle=Sci Rep：高CD3和ICOS及低TIM-3表达预测食管鳞状细胞癌切除后的生存率良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fef1186031b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795721, encodeId=96221e95721a8, content=<a href='/topic/show?id=3dc91e454d3' target=_blank style='color:#2F92EE;'>#TIM-3#</a>, objectTitle=CLIN CANCER RES：Tim-3+ Treg细胞在头颈部肿瘤患者中发挥抑制作用, objectType=article, longId=150045, objectId=cd5215004547, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd5215004547, replyNumber=0, likeNumber=40, createdTime=2019-01-07, rootId=0, userName=cmsvly, userId=aad0444, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd5215004547, moduleTitle=CLIN CANCER RES：Tim-3+ Treg细胞在头颈部肿瘤患者中发挥抑制作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd5215004547)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795720, encodeId=0c3a1e95720ea, content=<a href='/topic/show?id=3dc91e454d3' target=_blank style='color:#2F92EE;'>#TIM-3#</a>, objectTitle=EAU18∣肾癌中性粒细胞通过Galectin-9/Tim-3抑制CD8 + T细胞的抗肿瘤应答, objectType=article, longId=133356, objectId=12ea133356de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=12ea133356de, replyNumber=0, likeNumber=44, createdTime=2019-01-16, rootId=0, userName=cmsvly, userId=aad0444, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=12ea133356de, moduleTitle=EAU18∣肾癌中性粒细胞通过Galectin-9/Tim-3抑制CD8 + T细胞的抗肿瘤应答, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=12ea133356de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795718, encodeId=dd881e9571809, content=<a href='/topic/show?id=3dc91e454d3' target=_blank style='color:#2F92EE;'>#TIM-3#</a>, objectTitle=Tumour Biol：Tim-3作为前列腺癌药物作用靶点的分析, objectType=article, longId=105387, objectId=625110538e03, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=625110538e03, replyNumber=0, likeNumber=28, createdTime=2017-12-11, rootId=0, userName=cmsvly, userId=aad0444, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=625110538e03, moduleTitle=Tumour Biol：Tim-3作为前列腺癌药物作用靶点的分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=625110538e03)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795719, encodeId=81901e957196e, content=<a href='/topic/show?id=3dc91e454d3' target=_blank style='color:#2F92EE;'>#TIM-3#</a>, objectTitle=Histol Histopathol：结外NK/T细胞淋巴瘤中TIM-3和LAG-3的表达分析, objectType=article, longId=113961, objectId=8e1c11396103, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e1c11396103, replyNumber=0, likeNumber=34, createdTime=2018-09-04, rootId=0, userName=cmsvly, userId=aad0444, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e1c11396103, moduleTitle=Histol Histopathol：结外NK/T细胞淋巴瘤中TIM-3和LAG-3的表达分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e1c11396103)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

TIM-3

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#免疫治疗# #脑瘤# #DIPG# #TIM-3# #弥漫型内因性脑桥胶质瘤#

Cancer Cell：临床前研究显示阻断TIM-3是潜在的DIPG脑瘤免疫治疗方法

2024-01-24发表于陕西省

cmsvly (审核中...)

前往app查看评论内容

#TIM-3#

Clin Cancer Res：PD-L1抗体单药或联合TIM-3抗体在MSI-H/dMMR晚期肿瘤中的抗肿瘤活性和安全性

2022-07-06

cmsvly (审核中...)

前往app查看评论内容

#TIM-3#

Clin Cancer Res：α-PD-L1抗体±α-TIM-3抗体治疗MSI-H/dMMR肿瘤的活性和安全性

2022-07-05

cmsvly (审核中...)

前往app查看评论内容

#TIM-3#

Sci Rep：高CD3和ICOS及低TIM-3表达预测食管鳞状细胞癌切除后的生存率良好

2020-10-02

cmsvly (审核中...)

前往app查看评论内容

#TIM-3#

CLIN CANCER RES：Tim-3+ Treg细胞在头颈部肿瘤患者中发挥抑制作用

2019-01-07

cmsvly (审核中...)

前往app查看评论内容

#TIM-3#

EAU18∣肾癌中性粒细胞通过Galectin-9/Tim-3抑制CD8 + T细胞的抗肿瘤应答

2019-01-16

cmsvly (审核中...)

前往app查看评论内容

#TIM-3#

Tumour Biol：Tim-3作为前列腺癌药物作用靶点的分析

2017-12-11

cmsvly (审核中...)

前往app查看评论内容

#TIM-3#

Histol Histopathol：结外NK/T细胞淋巴瘤中TIM-3和LAG-3的表达分析

2018-09-04

科室
- - 订阅+
  - 更多科室
工具
服务